Global Prescription Drugs Market Poised for 10.7% Growth, Surpassing $2145.22 Billion by 2029

 

The prescription drug market size has grown rapidly in recent years. It will grow from $1289.77 billion in 2024 to $1430.3 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%.  The growth in the historic period can be attributed to the rising number of clinical trials, increasing availability of over-the-counter (OTC) products, rising need for daily prescriptions, rising healthcare costs, and increasing prevalence of several chronic disorders.

The prescription drug market size is expected to see rapid growth in the next few years. It will grow to $2145.22 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%.  The growth in the forecast period can be attributed to a rising number of clinical trials, increasing availability of over the counter (OTC) products, rising need for daily prescriptions, rising healthcare costs, and increasing prevalence of several chronic disorders. Major trends in the forecast period include demand for biologic drugs, advances in genomics and data analytics, awareness of mental health issues, expansion of digital health, and a shift toward preventive medications.

Get Your Free Sample of The Global Prescription Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20597&type=smp

What key drivers have fueled the prescription drugs market’s development over the years?
The increasing drug production is expected to propel the growth of the prescription drug market going forward. Drug production encompasses the organized process of creating pharmaceutical products, including their formulation, testing, and packaging, to guarantee quality, safety, and effectiveness. Increasing drug production is crucial to meet the growing global demand for medications, address public health challenges, and ensure the timely availability of treatments for diverse medical conditions. The increasing drug production can enhance the availability, affordability, and innovation in the prescription drug market, ultimately benefiting patients and the healthcare system by improving access to essential medications and supporting better health outcomes. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based organization representing the pharmaceutical sector, the European pharmaceutical industry experienced substantial production growth, rising from $352.48 billion in 2021 to $369.95 billion in 2022. Therefore, increasing drug production will drive the development of the prescription drug market.

What is the segmentation for the prescription drugs market?
The prescription drugs market covered in this report is segmented –
1) By Type: Branded, Generics
2) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration
3) By Therapy Area: Oncology, Immunology, Ophthalmology, Respiratory, Dermatology, Gastroenterology, Urology, Gynecology, Endocrinology, Other Therapy Areas
4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Branded: Innovative Drugs, Patented Drugs, Blockbuster Drugs, Over-the-Counter (OTC) Prescription Drugs, Biosimilars, Specialty Drugs, Orphan Drugs, Combination Drugs
2) By Generics: Small Molecule Generics, Generic Biologics, Over-the-Counter (OTC) Generics, Authorized Generics, Generic Combination Drugs, High-Volume Generics, Generic Versions Of Blockbuster Drugs

Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/prescription-drugs-global-market-report

Who are the most influential companies in the prescription drugs market?
Major companies operating in the prescription drugs market are Pfizer Inc., Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Allergan plc, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited

What are the top industry trends projected to impact the prescription drugs market?
Major companies operating in the prescription drug market are developing Victoza (liraglutide) alternatives or similar GLP-1 receptor agonist therapies to provide enhanced options for managing type 2 diabetes. Victoza is a brand-name prescription medication that contains the active ingredient liraglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist. It is used primarily to manage type 2 diabetes in adults and children aged 10 years and older. For instance, in June 2024, Teva Announces, an Israel-based company, launched Authorized Generic of Victoza (liraglutide injection 1.8mg), offering a more affordable alternative while maintaining the same formulation, efficacy, and quality as the original branded product. This launch aims to improve access to essential diabetes treatments for patients, providing cost-effective options for managing type 2 diabetes and reducing cardiovascular risks associated with the condition.

What are the major regional insights for the prescription drugs market, and which region holds the top position?
North America was the largest region in the prescription drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Does The Prescription Drugs Market Report 2025 Offer?
The prescription drugs market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Prescription drugs refer to medications that are legally available only with a valid prescription from a licensed healthcare provider, used to treat, manage, or prevent various medical conditions. It is used to diagnose, treat, manage, or prevent medical conditions under the supervision of a healthcare professional, ensuring the appropriate use and minimizing the risk of misuse or adverse effects.

Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20597

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model